Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 26;16(6):e63200.
doi: 10.7759/cureus.63200. eCollection 2024 Jun.

Monomeric C-Reactive Protein Potential Utilization in the Histological Assessment of Inflammatory Bowel Disease (IBD) Patients

Affiliations

Monomeric C-Reactive Protein Potential Utilization in the Histological Assessment of Inflammatory Bowel Disease (IBD) Patients

Simona Muresan et al. Cureus. .

Abstract

Introduction Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), represent chronic progressive inflammatory gastrointestinal disorders, without a single reference standard for their diagnosis. The histological assessment gained an important role in accurately measuring disease activity, and mucosal healing (MH) was recently proposed to be an ideal treatment goal for patients with IBD because of its favorable prognosis, with a lower risk of recurrence or surgical treatment. This paper aims to add to the histological classical findings for IBD patients the identification of the monomeric form of the C-reactive protein (mCRP) as a supplementary marker that could be stained at the level of tissue samples and could be correlated with the pathogenic mechanism. Methods Two groups of 10 patients were each selected for the study, for both UC and CD, together with a control group. All samples collected through digestive endoscopy were analyzed by using H&E-stained slides, followed by immunohistochemical examination with antibodies to mCRP (M8C10), and markers of inflammatory activity through CD3, CD45(leukocyte common antigen (LCA)), CD138/syndecan-1 and CD68. Results For the CD study group, all histological elements identified with H&E and afterward stained with CD138, CD68, CD3, and CD45/LCA were correlated with the standards imposed by the European Crohn's and Colitis Organization (ECCO). For the group of patients with UC, histological images obtained with H&E and IHC stainings also confirmed the recommendation of ECCO. The main cells considered in the literature as histological markers for IBD are neutrophils, lymphocytes, and plasmocytes, stained in our study with CD45/LCA, CD3, and CD138. For all 20 cases of IBD (UC and CD), the staining with anti-Ab8C10 antibodies for mCRP was positive, while negative results were noticed within the control group. An mCRP protein visualized with anti-Ab8C10 antibodies presented an intracytoplasmatic localization in the neutrophils, plasma cells, lymphocytes, and macrophages from the lamina propria and glandular epithelium, without expression in endothelial cells. Conclusions Our study represents one of the first papers that identifies the localization of mCRP molecules within the intestinal mucosa of patients with IBD (both UC and CD) by using immunohistochemistry (IHC) staining. This finding opens a new perspective for considering mCRP as a marker correlated with histological disease activity and/or definition of histological remission in IBD.

Keywords: crohn’s disease (cd); imunohistochemistry; inflammatory bowel disease; monomeric c-reactive protein; ulcerative colitis (uc).

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Ethic Committee of Research from George Emil Palade University of Medicine, Pharmacy, Science and Technology from Targu Mures and Ethic Comittee of County Hospital Targu Mures issued approval 3145 and 4416. Committee 1: Approval of the study; Committee 2: The committee approves the using of patient retrospective data. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Immunohistochemical staining of individual anti-Ab8C10 antibodies for mCRP in the control group
1A. Colonic mucosa with normal histological aspect (H&E, 10x) 1B. Colonic mucosa with normal histological aspect (H&E, 20x) 1C. Colonic mucosa with normal histological aspect (H&E, 40x) 1D. Normal colonic mucosa with negative staining for anti-Ab8C10 antibodies (10x) 1E. Normal colonic mucosa with negative staining for anti-Ab8C10 antibodies (20x) 1F. Normal colonic mucosa with negative staining for anti-Ab8C10 antibodies (40x) (10x: images are magnified to a size 10 times larger than the original; 20x: images are magnified to a size 20 times larger than the original; 40x: images are magnified to a size 40 times larger than the original)
Figure 2
Figure 2. Immunohistochemical staining of individual anti-Ab8C10 antibodies for mCRP in ulcerative colitis and Crohn’s disease
2A. Histology of ulcerative colitis with activity features in the lamina propria. Note the presence of neutrophils, plasma cells, lymphocytes in the lamina propria and glandular epithelium, highlighted with anti-Ab8C10 antibodies (40x) 2B. Histology of ulcerative colitis with a mild increase in lymphocytes and plasma cells within the lamina propria immunostained with anti-Ab8C10 antibodies (40x) 2C. Histology of ulcerative colitis with an abundant chronic inflammatory infiltrate in the lamina propria. Note the presence of a blood vessel with inflammatory cells in the lumen immunostained with anti-Ab8C10 antibodies, without the staining of endothelial cells (40x) 2D. Histology of Crohn’s disease with neutrophils in the lamina propria and in the surface epithelium highlighted with anti-Ab8C10 antibodies (40x) 2E. Histology of Crohn’s disease with an abundant lympho-plasmocytic infiltrate in the lamina propria highlighted with anti-Ab8C10 antibodies (40x) (mCRP: monomeric C-reactive protein; 40x: images are magnified to a size 40 times larger than the original)
Figure 3
Figure 3. Histological findings and immunohistochemical staining in ulcerative colitis
3A. Colonic mucosa with normal glandular architecture and moderate chronic inflammatory infiltrate in the lamina propria (H&E, 20x) 3B. Positive cytoplasmatic staining of plasma cells, lymphocytes and macrophages with anti-Ab8C10 antibodies for mCRP (20x) 3C. Positive membrane and cytoplasmatic staining of lymphocytes with anti-CD3 antibodies (20x) 3D. Positive cytoplasmatic staining of the macrophages with anti-CD68 antibodies (20X) 4E. Positive cytoplasmatic staining of plasma cells and lymphocytes with anti-LCA antibodies (20x) 3F. Positive cytoplasmatic staining of plasma cells with anti-CD138 antibodies (20x) (mCRP: monomeric C-reactive protein; 20x: images are magnified to a size 20 times larger than the original; LCA: leukocyte common antigen)
Figure 4
Figure 4. Histological findings and immunohistochemical staining in Crohn’s disease
4A. Colonic mucosa with a moderate chronic inflammatory infiltrate in the lamina propria and mild architectural distortions (H&E, 20x) 4B. Positive cytoplasmatic staining of plasma cells, lymphocytes, and macrophages with anti-Ab8C10 antibodies for mCRP (20x) 4C. Positive membrane and cytoplasmatic staining of lymphocytes with anti-CD3 antibodies (20x) 4D. Positive cytoplasmatic staining of the macrophages with anti-CD68 antibodies (20x) 4E. Positive cytoplasmatic staining of plasma cells and lymphocytes with anti-LCA antibodies (20x) 4F. Positive cytoplasmatic staining of plasma cells with anti-CD138 antibodies (20x) (mCRP: monomeric C-reactive protein; 20x: images are magnified to a size 20 times larger than the original; LCA: leukocyte common antigen)

References

    1. Changing treatment paradigms for the management of inflammatory bowel disease. Im JP, Ye BD, Kim YS, Kim JS. Korean J Intern Med. 2018;33:28–35. - PMC - PubMed
    1. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. Maaser C, Sturm A, Vavricka SR, et al. J Crohns Colitis. 2019;13:144–164. - PubMed
    1. C-reactive protein: an inflammatory biomarker and a predictor of neurodegenerative disease in patients with inflammatory bowel disease? Muresan S, Slevin M. Cureus. 2024;16:0. - PMC - PubMed
    1. Association between inflammatory bowel disease and risk of stroke: a systematic review and meta-analysis of cohort studies. Fan JS, Wang M, Chen N, Sun BC, Zhang QB, Li Y, Huang MJ. Front Neurol. 2023;14 - PMC - PubMed
    1. Inflammatory bowel disease and neurodegenerative diseases. Kim JS, Chen MH, Wang HE, Lu CL, Wang YP, Zhang B. Gut Liver. 2023;17:495–504. - PMC - PubMed

LinkOut - more resources